Search

everythinglearnresearchcommunity

for

Search:↓

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Androgens and other hormones affect hair growth and skin conditions like acne.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Researchers created a fully functional, bioengineered skin system with hair from stem cells that successfully integrated when transplanted into mice.

Hair loss in women may have causes other than hormones.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

The document concludes that hair loss in cats is caused by various factors, including allergies, mites, infections, and hormonal issues, with treatments varying accordingly.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Scientists have made progress in growing mini-organs and regenerating parts of the skin, with plans to treat hair loss in a future trial.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

A patient produced cortisol after adrenalectomy, possibly due to residual tissue or other body parts making steroids.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Neurosteroids show promise for treating epilepsy and more research is needed.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

The patient was diagnosed with anorexia nervosa and severe malnutrition, requiring urgent refeeding and monitoring.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.